Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Take advantage of all the amazing benefits, dont wait any longer
Q: Are There Better Ways to Measure Health Than BMI
The intensity of gastrointestinal symptoms typically correlates with dose escalation
GLP-1s and Addiction The authors of GLP-1 Therapeutics and Their Emerging Role in Alcohol and Substance Use Disorders: An Endocrinology Primer , appearing in October 2025 in JES, point out that the World Health Organization reported 890 million adults and 60 million children and adolescents had obesity in 2022 globally
Similar content being viewed by others Impact statements Healthcare professionals should be aware of the potential for psychiatric adverse events, particularly depression, anxiety and suicidal ideation associated with semaglutide, liraglutide, and tirzepatide
and Ritu Anand, M.D
